The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
Open accessAbstract
In addition to long-term regulation of angiogenesis, angiogenic growth factor signalling through nitric oxide (NO) acutely controls blood flow and haemostasis. Inhibition of this pathway may account for the hypertensive and pro-thrombotic side effects of the vascular endothelial growth factor antagonists that are currently used for cancer treatment. The first identified endogenous angiogenesis inhibitor, thrombospondin 1, also controls tissue perfusion, haemostasis and radiosensitivity by antagonizing NO signalling. We examine the role of these and other emerging activities of thrombospondin 1 in cancer. Clarifying how endogenous and therapeutic angiogenesis inhibitors regulate vascular NO signalling could facilitate development of more selective inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhu, W., & Smart, E. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501238200 · Cited by 36
RetractedActivation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,593
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski, M. W., Palmer, R. M., & Moncada, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5193 · Cited by 1,208
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,020
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.-O., Buerk, D. G., Huang, P. L., & Jain, R. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041359198 · Cited by 1,020
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
The chemical biology of nitric oxide: Implications in cellular signaling
Thomas, D. D., Ridnour, L. A., Isenberg, J. S., Flores-Santana, W., Switzer, C. H., Donzelli, S., Hussain, P., Vecoli, C., Paolocci, N., Ambs, S., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.020 · Cited by 975
Self-citationIntegrin-associated protein (CD47) and its ligands
Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 878
Italiano, J. E., Richardson, J. L., Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., Ryeom, S., Folkman, J., & Klement, G. L. (2008) · Blood · doi:10.1182/blood-2007-09-113837 · Cited by 859
Overview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 796
Cellular abnormalities of blood vessels as targets in cancer
Baluk, P., Hashizume, H., & McDonald, D. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.005 · Cited by 781
Nalluri, S. R., Chu, D., Keresztes, R., Zhu, X., & Wu, S. (2008) · JAMA · doi:10.1001/jama.2008.656 · Cited by 771
Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.
Ignarro, L. J. (2002) · PubMed · Cited by 753
Corneal avascularity is due to soluble VEGF receptor-1
Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R. J. C., Richter, E., Sakurai, E., Newcomb, M. T., et al. (2006) · Nature · doi:10.1038/nature05249 · Cited by 684
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A., & Bouck, N. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.707 · Cited by 676
Munder, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5347 · Cited by 647
Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Loscalzo, J. (2001) · Circulation Research · doi:10.1161/hh0801.089861 · Cited by 612
Tolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Siegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., Chen, H., Clark-Garvey, S., Weinberg, A., Mandeli, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9947 · Cited by 506
Rodríguez-Manzaneque, J. C., Lane, T. F., Ortega, M. A., Hynes, R. O., Lawler, J., & Iruela-Arispe, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171460498 · Cited by 473
Butt, E., Abel, K., Krieger, M., Palm, D., Hoppe, V., Hoppe, J., & Walter, U. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36652-8 · Cited by 468
Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
Ku, D. D., Zaleski, J. K., Liu, S., & Brock, T. A. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.2.h586 · Cited by 445
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Moeller, B. J., Richardson, R. A., & Dewhirst, M. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9056-0 · Cited by 415
Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
Bocci, G., Francia, G., Man, S., Lawler, J., & Kerbel, R. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135406100 · Cited by 414
Taraboletti, G., Roberts, D., Liotta, L. A., & Giavazzi, R. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.765 · Cited by 411
Self-citationIntegrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin
Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., & Frazier, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.21 · Cited by 402
Life history of eNOS: partners and pathways
DUDZINSKI, D., & MICHEL, T. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.023 · Cited by 400
Wu, S., Chen, J. J., Kudelka, A., Lu, J., & Zhu, X. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70003-2 · Cited by 386
Weinstat‐Saslow, D., Zabrenetzky, V. S., VanHoutte, K., Frazier, W. A., Roberts, D. D., & Steeg, P. S. (1994) · PubMed · Cited by 348
Self-citationGenetic heterogeneity of the vasculogenic phenotype parallels angiogenesis
Shaked, Y., Bertolini, F., Man, S., Rogers, M. S., Cervi, D., Foutz, T., Rawn, K., Voskas, D., Dumont, D. J., Ben-David, Y., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.023 · Cited by 324
Endogenous angiogenesis inhibitors
FOLKMAN, J. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0809.x · Cited by 321
Ridnour, L. A., Thomas, D. D., Mancardi, D., Espey, M. G., Miranda, K. M., Paolocci, N., Feelisch, M., Fukuto, J., & Wink, D. A. (2004) · Biological Chemistry · doi:10.1515/bc.2004.001 · Cited by 312
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics
Kim-Shapiro, D. B., Schechter, A. N., & Gladwin, M. T. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000204350.44226.9a · Cited by 308
Iruela-Arispe, M. L., Lombardo, M., Krutzsch, H. C., Lawler, J., & Roberts, D. D. (1999) · Circulation · doi:10.1161/01.cir.100.13.1423 · Cited by 308
Self-citationThrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
Streit, M., Riccardi, L., Velasco, P., Brown, L. F., Hawighorst, T., Bornstein, P., & Detmar, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14888 · Cited by 302
Agah, A., Kyriakides, T. R., Lawler, J., & Bornstein, P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64243-5 · Cited by 300
Isenberg, J. S., Ridnour, L. A., Dimitry, J., Frazier, W. A., Wink, D. A., & Roberts, D. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605040200 · Cited by 289
Self-citationDings, R. P. M., Loren, M., Heun, H., McNiel, E., Griffioen, A. W., Mayo, K. H., & Griffin, R. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2441 · Cited by 286
Streit, M., Velasco, P., Brown, L. F., Skobe, M., Richard, L., Riccardi, L., Lawler, J., & Detmar, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65140-1 · Cited by 279
Thrombospondins: from structure to therapeutics: Thrombospondins in cancer
Kazerounian, S., Yee, K. O., & Lawler, J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7486-z · Cited by 277
Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner
Isenberg, J. S., Ridnour, L. A., Perruccio, E. M., Espey, M. G., Wink, D. A., & Roberts, D. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502977102 · Cited by 273
Self-citationCD36: Implications in cardiovascular disease
Febbraio, M., & Silverstein, R. L. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.012 · Cited by 247
Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac Performance
Yang, R., Thomas, G. R., Bunting, S., Ko, A., Ferrara, N., Keyt, B., Ross, J., & Jin, H. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199606000-00011 · Cited by 244
van Doorn, R., Zoutman, W. H., Dijkman, R., de Menezes, R. X., Commandeur, S., Mulder, A. A., van der Velden, P. A., Vermeer, M. H., Willemze, R., Yan, P. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.353 · Cited by 228
Zabrenetzky, V., Harris, C. C., Steeg, P. S., & Roberts, D. D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590209 · Cited by 219
Self-citationDifferentiation of lobular versus ductal breast carcinomas by expression microarray analysis.
Korkola, J. E., DeVries, S., Fridlyand, J., Hwang, E. S., Estep, A. L., Chen, Y. Y., Chew, K., Dairkee, S. H., Jensen, R. M., & Waldman, F. M. (2003) · PubMed · Cited by 219
Isenberg, J. S., Romeo, M. J., Yu, C., Yu, C. K., Nghiem, K., Monsale, J., Rick, M. E., Wink, D. A., Frazier, W. A., & Roberts, D. D. (2008) · Blood · doi:10.1182/blood-2007-06-098392 · Cited by 205
Self-citationRole of Nitric Oxide in the Angiogenic Response In Vitro to Basic Fibroblast Growth Factor
Babaei, S., Teichert-Kuliszewska, K., Monge, J.-C., Mohamed, F., Bendeck, M. P., & Stewart, D. J. (1998) · Circulation Research · doi:10.1161/01.res.82.9.1007 · Cited by 205
Signal Regulatory Proteins in the Immune System
van Beek, E. M., Cochrane, F., Barclay, A. N., & van den Berg, T. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7781 · Cited by 204
Erratum: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/23523 · Cited by 204
Degryse, B., Neels, J. G., Czekay, R.-P., Aertgeerts, K., Kamikubo, Y.-I., & Loskutoff, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313004200 · Cited by 201
Molecular mechanisms for discrete nitric oxide levels in cancer
Ridnour, L. A., Thomas, D. D., Switzer, C., Flores-Santana, W., Isenberg, J. S., Ambs, S., Roberts, D. D., & Wink, D. A. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.006 · Cited by 196
Self-citationThrombospondins: from structure to therapeutics: Structures of thrombospondins
Carlson, C. B., Lawler, J., & Mosher, D. F. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7484-1 · Cited by 194
Patel, T. V., Morgan, J. A., Demetri, G. D., George, S., Maki, R. G., Quigley, M., & Humphreys, B. D. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm311 · Cited by 192
Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1
Volpert, O. V., Pili, R., Sikder, H. A., Nelius, T., Zaichuk, T., Morris, C., Shiflett, C. B., Devlin, M. K., Conant, K., & Alani, R. M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00209-x · Cited by 190
Steeghs, N., Gelderblom, H., Roodt, J. O. '., Christensen, O., Rajagopalan, P., Hovens, M., Putter, H., Rabelink, T. J., & de Koning, E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5050 · Cited by 190
Volpert, O. V., Lawler, J., & Bouck, N. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6343 · Cited by 186
Angiogenic Actions of Angiopoietin-1 Require Endothelium-Derived Nitric Oxide
Babaei, S., Teichert-Kuliszewska, K., Zhang, Q., Jones, N., Dumont, D. J., & Stewart, D. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64326-x · Cited by 183
Perivascular nitric oxide gradients normalize tumor vasculature
Kashiwagi, S., Tsukada, K., Xu, L., Miyazaki, J., Kozin, S. V., Tyrrell, J. A., Sessa, W. C., Gerweck, L. E., Jain, R. K., & Fukumura, D. (2008) · Nature Medicine · doi:10.1038/nm1730 · Cited by 183
Jadeski, L. C., Hum, K. O., Chakraborty, C., & Lala, P. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<30::aid-ijc5>3.0.co;2-i · Cited by 180
Endocytic receptor LRP together with tPA and PAI‐1 coordinates Mac‐1‐dependent macrophage migration
Cao, C., Lawrence, D. A., Li, Y., Von Arnim, C. A., Herz, J., Su, E. J., Makarova, A., Hyman, B. T., Strickland, D. K., & Zhang, L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601082 · Cited by 175
Jadeski, L. C., & Lala, P. K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65240-6 · Cited by 174
Chandrasekaran, L. K., He, C.-Z., Al-Barazi, H., Krutzsch, H. C., Iruela‐Arispe, M. L., & Roberts, D. D. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.9.2885 · Cited by 172
Self-citationMethylation and silencing of the Thrombospondin-1 promoter in human cancer
Li, Q., Ahuja, N., Burger, P. C., & Issa, J.-P. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202663 · Cited by 171
The collected works of Sir Humphry Davy /
Davy, H., & Davy, J. (1839) · Biodiversity Heritage Library (Smithsonian Institution) · doi:10.5962/bhl.title.51041 · Cited by 167
Structure of a thrombospondin C‐terminal fragment reveals a novel calcium core in the type 3 repeats
Kvansakul, M., Adams, J. C., & Hohenester, E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600166 · Cited by 166
Shindo, T., Kurihara, H., Maemura, K., Kurihara, Y., Kuwaki, T., Izumida, T., Minamino, N., Ju, K.-H., Morita, H., Oh-hashi, Y., et al. (2000) · Circulation · doi:10.1161/01.cir.101.19.2309 · Cited by 166
Sheibani, N., & Frazier, W. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6788 · Cited by 161
Linderholm, B., Lindh, B., Tavelin, B., Grankvist, K., & Henriksson, R. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000120)89:1<51::aid-ijc9>3.0.co;2-8 · Cited by 158
Interactions between CD47 and Thrombospondin Reduce Inflammation
Lamy, L., Foussat, A., Brown, E. J., BORNSTEIN, P. K., Ticchioni, M., & Bernard, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5930 · Cited by 157
Isenberg, J. S., Annis, D. S., Pendrak, M. L., Ptaszynska, M. M., Frazier, W. A., Mosher, D. F., & Roberts, D. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804860200 · Cited by 152
Self-citationStraume, O., & Akslen, L. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61688-4 · Cited by 151
Hawighorst, T., Velasco, P., Streit, M., Hong, Y., Kyriakides, T. R., Brown, L. F., Bornstein, P., & Detmar, M. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2631 · Cited by 148
Taraboletti, G., Morbidelli, L., Donnini, S., Parenti, A., Granger, H. J., Giavazzi, R., & Ziche, M. (2000) · The FASEB Journal · doi:10.1096/fj.99-0931fje · Cited by 148
Duval, M., Bœuf, F. L., Huot, J., & Gratton, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0467 · Cited by 143
Haviv, F., Bradley, M. F., Kalvin, D. M., Schneider, A. J., Davidson, D. J., Majest, S. M., McKay, L. M., Haskell, C. J., Bell, R. L., Nguyen, B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0401560 · Cited by 142
Urbich, C., Reissner, A., Chavakis, E., Dernbach, E., Haendeler, J., Fleming, I., Zeiher, A. M., Kaszkin, M., & Dimmeler, S. (2002) · The FASEB Journal · doi:10.1096/fj.01-0637fje · Cited by 139
Pathogenesis of renal ischemia/reperfusion injury: lessons from knockout mice
Lien, Y.-H. H., Lai, L.-W., & Silva, A. L. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.08.001 · Cited by 139
CD47 Mediates Killing of Breast Tumor Cells via Gi-Dependent Inhibition of Protein Kinase A
Manna, P. P., & Frazier, W. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1708 · Cited by 139
Thrombospondin-1 Inhibits Nitric Oxide Signaling via CD36 by Inhibiting Myristic Acid Uptake
Isenberg, J. S., Jia, Y., Fukuyama, J., Switzer, C., Wink, D. A., & Roberts, D. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701638200 · Cited by 137
Self-citationThe effect of thrombospondin-1 on breast cancer metastasis
Yee, K. O., Connolly, C. M., Duquette, M. A., Kazerounian, S., Washington, R. W., & Lawler, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9992-6 · Cited by 137
Thrombospondins: from structure to therapeutics
Isenberg, J. S., Frazier, W. A., & Roberts, D. D. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7488-x · Cited by 136
Self-citationNitric oxide insufficiency and atherothrombosis
Voetsch, B., Jin, R. C., & Loscalzo, J. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0675-z · Cited by 134
Torre, C. A. D., Yoshimoto, M., Lee, C.-H., Joshua, A. M., de Toledo, S. R., Petrilli, A. S., Andrade, J. A. D., Chilton‐MacNeill, S., Zieleńska, M., & Squire, J. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-237 · Cited by 133
Gladwin, M. T., Schechter, A. N., Shelhamer, J. H., Pannell, L. K., Conway, D. A., Hrinczenko, B. W., Nichols, J. S., Pease‐Fye, M. E., Noguchi, C. T., Rodgers, G. P., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7637 · Cited by 133
Chemical modification of tumour blood flow
Jirtle, R. L. (1988) · International Journal of Hyperthermia · doi:10.3109/02656738809016490 · Cited by 133
Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses
Isenberg, J. I., Wink, D. A., & Roberts, D. D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.024 · Cited by 133
Self-citationMartin‐Manso, G., Galli, S., Ridnour, L. A., Tsokos, M., Wink, D. A., & Roberts, D. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0643 · Cited by 130
Self-citationIsenberg, J. S., Hyodo, F., Matsumoto, K.-I., Romeo, M. J., Abu-Asab, M. S., Tsokos, M., Kuppusamy, P., Wink, D. A., Krishna, M. C., & Roberts, D. D. (2006) · Blood · doi:10.1182/blood-2006-08-041368 · Cited by 124
Self-citationIncreasing Survival of Ischemic Tissue by Targeting CD47
Isenberg, J. S., Romeo, M. J., Abu-Asab, M. S., Tsokos, M., Oldenborg, A., Pappan, L. K., Wink, D. A., Frazier, W. A., & Roberts, D. D. (2007) · Circulation Research · doi:10.1161/01.res.0000259579.35787.4e · Cited by 122
Self-citationInvolvement of Endothelial Nitric Oxide in Sphingosine-1-Phosphate–Induced Angiogenesis
Rikitake, Y., Hirata, K., Kawashima, S., Ozaki, M., Takahashi, T., Ogawa, W., Inoue, N., & Yokoyama, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101843 · Cited by 121
Simantov, R., Febbraio, M., & Silverstein, R. L. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.11.005 · Cited by 120
Ludwig, R. J., Schön, M. P., & Boehncke, W. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.1103 · Cited by 120
Haemodynamic and Transport Barriers to the Treatment of Solid Tumours
Jain, R. K., Cook, A. W., & Steele, E. L. (1991) · International Journal of Radiation Biology · doi:10.1080/09553009114551621 · Cited by 119
Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice
Lawler, J., Miao, W., Duquette, M. A., Bouck, N., Bronson, R. T., & Hynes, R. O. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63042-8 · Cited by 117
Calzada, M. J., Zhou, L., Sipes, J. M., Zhang, J., Krutzsch, H. C., Iruela‐Arispe, M. L., Annis, D. S., Mosher, D. F., & Roberts, D. D. (2003) · Circulation Research · doi:10.1161/01.res.0000115555.05668.93 · Cited by 116
Self-citationInteraction of α9β1 Integrin With Thrombospondin-1 Promotes Angiogenesis
Staniszewska, I., Zaveri, S., Valle, L. D., Oliva, I. B., Rothman, V. L., Croul, S. E., Roberts, D. D., Mosher, D. F., Tuszynski, G. P., & Marcinkiewicz, C. (2007) · Circulation Research · doi:10.1161/01.res.0000266662.98355.66 · Cited by 116
Self-citationThrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress
Isenberg, J. S., Qin, Y., Maxhimer, J. B., Sipes, J. M., Despres, D., Schnermann, J. B., Frazier, W. A., & Roberts, D. D. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.01.002 · Cited by 112
Self-citationRecognition of the N-terminal Modules of Thrombospondin-1 and Thrombospondin-2 by α6β1 Integrin
Calzada, M. J., Sipes, J. M., Krutzsch, H. C., Yurchenco, P. D., Annis, D. S., Mosher, D. F., & Roberts, D. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302014200 · Cited by 111
Self-citationA Phase II Study of ABT-510 (Thrombospondin-1 Analog) for the Treatment of Metastatic Melanoma
Markovic, S. N., Suman, V. J., Rao, R. A., Ingle, J. N., Kaur, J. S., Erickson, L. A., Pitot, H. C., Croghan, G. A., McWilliams, R. R., Merchan, J. R., et al. (2007) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000256104.80089.35 · Cited by 109
Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis
Hussain, S. P., He, P., Subleski, J. J., Hofseth, L. J., Trivers, G. E., Mechanic, L. E., Hofseth, A. B., Bernard, M., Schwank, J., Nguyen, G. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0410 · Cited by 108
Soluble guanylyl cyclase: more secrets revealed
Pyriochou, A., & Papapetropoulos, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.09.008 · Cited by 106
Tumor Cell Radiosensitivity Is a Major Determinant of Tumor Response to Radiation
Gerweck, L. E., Vijayappa, S., Kurimasa, A., Ogawa, K., & Chen, D. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0533 · Cited by 106
Nitric oxide activation of guanylyl cyclase in cells revisited
Roy, B., & Garthwaite, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602544103 · Cited by 100
Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma
Poon, R. T. P., Chung, K. K., Cheung, S., Lau, C. P.-Y., Tong, S. W., Leung, K. L., Yu, W. C., Tuszynski, G. P., & Fan, S. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0435 · Cited by 98
Yap, R. L., Veliceasa, D., Emmenegger, U., Kerbel, R. S., McKay, L. M., Henkin, J., & Volpert, O. V. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0621 · Cited by 97
Phase 2 Study of ABT-510 in Patients with Previously Untreated Advanced Renal Cell Carcinoma
Ebbinghaus, S., Hussain, M., Tannir, N. M., Gordon, M. S., Desai, A. A., Knight, R. A., Humerickhouse, R. A., Qian, J. X., Gordon, G., & Figlin, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1477 · Cited by 95
Isenberg, J. S., Hyodo, F., Pappan, L. K., Abu-Asab, M. S., Tsokos, M., Krishna, M. C., Frazier, W. A., & Roberts, D. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155390 · Cited by 95
Self-citationThrombospondins: from structure to therapeutics
Bonnefoy, A., de Moura, R. J., & Hoylaerts, M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7487-y · Cited by 94
Hawighorst, T., Oura, H., Streit, M., Janes, L., Nguyen, L., Brown, L. F., Oliver, G. C., Jackson, D. G., & Detmar, M. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205956 · Cited by 94
Chemotherapy agents and hypertension: A focus on angiogenesis blockade
Jain, M. K., & Townsend, R. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0058-7 · Cited by 92
AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production
Reihill, J. A., Ewart, M., Hardie, D. G., & Salt, I. P. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.110 · Cited by 91
Activation of the Myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA
Janz, A., Sevignani, C., Kenyon, K., Ngo, C. V., & Thomas-Tikhonenko, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.11.2268 · Cited by 89
Thrombospondin-1 and CD47 Limit Cell and Tissue Survival of Radiation Injury
Isenberg, J. S., Maxhimer, J. B., Hyodo, F., Pendrak, M. L., Ridnour, L. A., DeGraff, W., Tsokos, M., Wink, D. A., & Roberts, D. D. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080237 · Cited by 88
Self-citationBaker, L. H., Rowinsky, E. K., Mendelson, D. S., Humerickhouse, R. A., Knight, R. A., Qian, J. X., Carr, R. A., Gordon, G., & Demetri, G. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.4706 · Cited by 87
Blockade of Thrombospondin-1-CD47 Interactions Prevents Necrosis of Full Thickness Skin Grafts
Isenberg, J. S., Pappan, L. K., Romeo, M. J., Abu-Asab, M. S., Tsokos, M., Wink, D. A., Frazier, W. A., & Roberts, D. D. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815685dc · Cited by 87
Self-citationHypertension secondary to anti-angiogenic therapy: experience with bevacizumab.
Pande, A. U., Lombardo, J. C., Spangenthal, E. J., et al. (2007) · PubMed · Cited by 85
Curwen, J., Musgrove, H. L., Kendrew, J., Richmond, G. H. P., Ogilvie, D., & Wedge, S. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4783 · Cited by 82
The N-terminus of thrombospondin: the domain stands apart
Elzie, C. A., & Murphy-Ullrich, J. E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.12.012 · Cited by 79
Treatment of liver ischemia–reperfusion injury by limiting thrombospondin-1/CD47 signaling
Isenberg, J. S., Maxhimer, J. B., Powers, P., Tsokos, M., Frazier, W. A., & Roberts, D. D. (2008) · Surgery · doi:10.1016/j.surg.2008.07.009 · Cited by 79
Self-citationKikuchi, Y., Uno, S., Kinoshita, Y., Yoshimura, Y., Iida, S.-I., Wakahara, Y., Tsuchiya, M., Yamada‐Okabe, H., & Fukushima, N. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.09.005 · Cited by 72
Guo, N.-H., Krutzsch, H. C., Inman, J. K., Shannon, C. S., & Roberts, D. D. (1997) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1997.tb01187.x · Cited by 70
Self-citationAnderson, J. C., Grammer, J. R., Wang, W., Nabors, B., Henkin, J., Stewart, J. E., & Gladson, C. L. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.3.3630 · Cited by 69
Huang, H., Campbell, S. C., Bedford, D. F., Nelius, T., Veliceasa, D., Shroff, E. H., Henkin, J., Schneider, A. J., Bouck, N., & Volpert, O. V. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.541.2.10 · Cited by 69
Influence of Tumor Cell and Stroma Sensitivity on Tumor Response to Radiation
Ogawa, K., Boucher, Y., Kashiwagi, S., Fukumura, D., Chen, D. J., & Gerweck, L. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4498 · Cited by 66
Thrombospondins, Their Polymorphisms, and Cardiovascular Disease
Stenina‐Adognravi, O., Topol, E. J., & Plow, E. F. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.141713 · Cited by 66
Isenberg, J. S., Romeo, M. J., Maxhimer, J. B., Smedley, J. V., Frazier, W. A., & Roberts, D. D. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31816c4006 · Cited by 64
Self-citationAgonist-Stimulated Endothelial Nitric Oxide Synthase Activation and Vascular Relaxation
Fulton, D. J., Ruan, L., Sood, S. G., Li, C., Zhang, Q., & Venema, R. C. (2007) · Circulation Research · doi:10.1161/circresaha.107.162933 · Cited by 62
Urano, T., Ito, Y., Akao, M., Sawa, T., Miyata, K., Tabata, M., Morisada, T., Hato, T., Yano, M., Kadomatsu, T., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149674 · Cited by 59
Molecular prognostic markers in resectable colorectal liver metastases: A systematic review
Neal, C. P., Garcea, G., Doucas, H., Manson, M. M., Sutton, C. D., Dennison, A. R., & Berry, D. P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.056 · Cited by 59
Expression of angiostatic factors in colorectal cancer.
Yoshida, Y., Oshika, Y., Fukushima, Y., et al. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.6.1221 · Cited by 56
Wei, D., Richardson, E. L., Zhu, K., Wang, L., Le, X., He, Y., Huang, S., & Xie, K. (2003) · PubMed · Cited by 55
Gietema, J. A., Hoekstra, R., Vos, F. D., Uges, D. R. A., van der Gaast, A., Groen, H. J. M., Loos, W. J., Knight, R. A., Carr, R. A., Humerickhouse, R. A., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl102 · Cited by 49
Plasma thrombospondin levels in patients with colorectal carcinoma
Yamashita, Y., Kurohiji, T., Tuszynski, G. P., Sakai, T., & Shirakusa, T. (1998) · Cancer · Cited by 47
Thrombospondin 1 and Vasoactive Agents Indirectly Alter Tumor Blood Flow
Isenberg, J. S., Hyodo, F., Ridnour, L. A., Shannon, C. S., Wink, D. A., Krishna, M. C., & Roberts, D. D. (2008) · Neoplasia · doi:10.1593/neo.08264 · Cited by 45
Self-citationIsenberg, J. S., Yu, C., & Roberts, D. D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.025 · Cited by 45
Self-citationHoekstra, R., Vos, F. D., Eskens, F. A. L. M., de Vries, E. G. E., Uges, D. R. A., Knight, R., Carr, R. A., Humerickhouse, R. A., Verweij, J., & Gietema, J. A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.040 · Cited by 44
TSP1 and MMP9 genetic variants in sporadic prostate cancer
Sfar, S., Saad, H., Mosbah, F., Gabbouj, S., & Chouchane, L. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.07.014 · Cited by 43
A Novel Enzyme Immunoassay for Plasma Thrombospondin
Bergseth, G., Lappegård, K. T., Videm, V., & Mollnes, T. E. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00226-7 · Cited by 42
Straume, O., & Akslen, L. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602792 · Cited by 42
Phosphodiesterase 5 inhibition in essential hypertension
Ghiadoni, L., Versari, D., & Taddei, S. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0011-4 · Cited by 40
Koch, W., Hoppmann, P., de Waha, A., Schömig, A., & Kastrati, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn001 · Cited by 40
Thrombospondins: from structure to therapeutics
Posey, K. L., Yang, Y. M., Veerisetty, A. C., Sharan, S. K., & Hecht, J. T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7485-0 · Cited by 38
Assessment of Genetic Risk Factors for Thoracic Aortic Aneurysm in Hypertensive Patients
Kato, K., Oguri, M., Kato, N., Hibino, T., Yajima, K., Yoshida, T., Metoki, N., Yoshida, H., Satoh, K., Watanabe, S., et al. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.229 · Cited by 36
van Heeckeren, W. J., Sanborn, S. L., Narayan, A., Cooney, M. M., McCrae, K. R., Schmaier, A. H., & Remick, S. C. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282a6457f · Cited by 36
McDonald, J. F., Dimitry, J. M., & Frazier, W. A. (2003) · Biochemistry · doi:10.1021/bi0341408 · Cited by 35
Liu, A., Mosher, D. F., Murphy-Ullrich, J. E., & Goldblum, S. E. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.08.008 · Cited by 32
Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition
Dony, E., Lai, Y., Dumitrascu, R., Pullamsetti, S. S., Savai, R., Ghofrani, H. A., Weißmann, N., Schudt, C., Flockerzi, D., Seeger, W., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00002007 · Cited by 32
Cartilage oligomeric matrix protein expression in hepatocellular carcinoma and the cirrhotic liver
XIAO, Y., Kleeff, J. H., Guo, J., Gazdhar, A., Liao, Q., Cesare, P. E. D., Büchler, M. W., & Frieß, H. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2003.03268.x · Cited by 27
Hu, D., Dyke, S. O. M., Moore, A. M., Thomsen, L. L., & Brindle, K. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1807 · Cited by 24
Shankar, A., Loizidou, M., Burnstock, G., & Taylor, I. (1999) · British journal of surgery · doi:10.1046/j.1365-2168.1999.01045.x · Cited by 22
Karavasilis, V., Malamou‐Mitsi, V., Briasoulis, E. C., Tsanou, E., Kitsou, E., & Pavlidis, N. (2006) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-00009577-200602001-00039 · Cited by 21
Jackson, E. B., Mukhopadhyay, S., & Tulis, D. A. (2007) · Current Vascular Pharmacology · doi:10.2174/1570161110705010001 · Cited by 17
Evidence for the Extrapulmonary Localization of Inhaled Nitric Oxide
Lecour, S., Clermont, G., du Toit, E. N., Gilson, L., Maupoil, V., Lowe, S., Dupuis, P., Girard, C., & Rochette, L. (2003) · Heart Disease · doi:10.1097/01.hdx.0000098613.53486.08 · Cited by 10
Cited by
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
Lawler, P. R., & Lawler, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006627 · Cited by 532
Adams, J. C., & Lawler, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009712 · Cited by 457
Matricellular Proteins in Cardiac Adaptation and Disease
Frangogiannis, N. G. (2012) · Physiological Reviews · doi:10.1152/physrev.00008.2011 · Cited by 445
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Cabanillas, M. E., Ryder, M., & Jimenez, C. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00007 · Cited by 335
Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue
Herrmann, J., Yang, E. H., Iliescu, C. A., Cilingiroglu, M., Charitakis, K., Hakeem, A., Toutouzas, K., Leesar, M. A., Grines, C. L., & Marmagkiolis, K. (2016) · Circulation · doi:10.1161/circulationaha.115.018347 · Cited by 329
Metadata
- Authors
- Isenberg, J. S., Martin-Manso, G., Maxhimer, J. B., & Roberts, D. D.
- Venue
- Nature Reviews Cancer
- Published
- 2009-02-05
- Volume
- 9
- Issue
- 3
- Pages
- 182-194
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2009523688
- Cited by
- 305
- References
- 159
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.